Addiction Management Technology Co. Available

This opportunity is for the full acquisition of an Addiction Management Technology Company that provides critical solutions for the 3 million+ Americans suffering from Opioid Use Disorder (OUD).

FDA-approved medication (e.g. Methadone) is available for treating OUD resulting from prescription drugs, like OxyContin®, or from illicit fentanyl, heroin, and other opiates, but affected individuals must receive Methadone daily from a clinic.

Platform for Take-Home Methadone
• Specialized lockbox merging secure medication dispenser with cloud-deployed analytics
• Ensures daily, safe, timely medication delivery
• Product is revenue-generating (launched 8/2024)
• FDA listed Class 1 device

Patient Benefits
• Reduces patient need to visit clinic from daily to every 14 days
• Reduces patient stigma and empowers individual recovery
• Expands geographic footprint medication accessibility

Provider Benefits
• Real-time visibility to patient compliance at home

Platform for High-Risk Medication Management
• Extended applications for management of substances with high abuse potential, such as Stimulants
• May provide market share driving feature to Pharma company with undifferentiated Ritalin® product
• Potential to collaborate with multiple Pharma entities for companion technology

This seasoned and experienced team is focused on enabling new roads to substance use disorder recovery and prevention. They are committed to providing medical technology solutions that reduce stigma and preserve personal dignity and independence for individuals in recovery. Additionally, they aim to support the overall healthcare ecosystem in a societal quest to prevent future challenges for our communities.

Available for Full Acquisition or Acquisition with Carve-Out Grant Back